Choosing a Zygomatic Implant: Why Technique Matters More Than Brand

Why This Is Not a Brand Question

Zygomatic implants are long implants anchored in the cheekbone, used in selected cases of severe upper jaw bone loss. Searching for the "best brand" misses what actually determines the outcome here: case selection, surgical technique and the management of complications matter far more than the name on the implant.

This article deliberately does not recommend a product or claim a particular system is used. What it sets out is what the published evidence says about outcomes and complications, so you can ask better questions.

What the Evidence Base Looks Like

An ITI consensus statement on zygomatic implants draws on 24 studies covering 918 patients. It reports survival rates ranging between 90.3% and 100% after a follow-up of six months, and immediately adds that there are many factors potentially altering the final outcomes.

Two things are worth taking from that. The range is wide, and six months is a short follow-up for a decision of this size. A single figure from within that range, quoted as your expected result, would not be an honest use of the data.

The same statement notes that failure is mostly seen within the first six months.

The Complications That Are Actually Reported

This is where the evidence is more useful than any survival number. From the same consensus:

• Maxillary sinusitis was the most reported complication. Pooled incidence was 9.5% with the original surgical technique, with a range across studies of 0–37.5%, and 4.4% with the anatomy-guided approach, range 0–11.8%. The statement notes most studies did not distinguish symptomatic from asymptomatic cases. This is based on descriptive data from 864 patients.

• Transient infraorbital nerve paresthesia reported in 15 citations.

• Oro-antral communications reported in 15 studies.

• Peri-abutment soft tissue recession or hyperplasia reported in 16 studies.

• Fractured implants described in six cases.

• Intraoperative complications including implant malposition, orbital cavity penetration — reported in four cases across three studies, one with damage to the lateral rectus muscle — and subcutaneous emphysema around the cheek.

These are not reasons to refuse the treatment where it is genuinely indicated. They are the reasons it belongs in experienced hands, with a plan for managing problems, and why it is not offered as a routine shortcut past bone grafting.

Note that the surgical technique changed the sinusitis figure more than any product choice would. That is the useful finding.

What to Ask Instead of "Which Brand?"

• Why is a zygomatic implant being proposed rather than grafting or another approach? The alternatives belong in the discussion — see implant options where bone is lost.

• Which surgical technique is planned, and why?

• What is the plan if sinusitis develops afterwards, and who manages it?

• How is follow-up arranged if I live in another country?

• What happens if an implant fails — given that failure is mostly seen in the first six months, and I may have returned home by then?

That last question matters more for patients travelling for treatment than any specification sheet.

Aftercare and Follow-Up

Because the implant passes close to the sinus, symptoms involving the nose and sinuses are relevant afterwards and should be reported rather than waited out. Report any change in vision or difficulty breathing as an emergency rather than by message.

Long-term maintenance follows the same principles as other implants, and the tissues around the abutments need monitoring — soft tissue recession and hyperplasia around abutments are among the more commonly reported findings. See implant care and cleaning.

Frequently Asked Questions

Which zygomatic implant brand is best?

That is not the determining factor. The consensus data show technique affecting the commonest complication substantially; product choice is not where the evidence points.

Is a zygomatic implant a way to avoid bone grafting?

It can avoid grafting in selected cases of severe upper jaw atrophy, but it is a more complex operation, not a simpler alternative, and it is not suitable for everyone.

What survival rate can I expect?

No individual figure can be given. The published range across 24 studies was 90.3% to 100% at six months, with many factors affecting outcomes — that is a range for studied groups, not a forecast for you.

Can this be planned before I travel?

A preliminary review of existing records is possible, but suitability and technique are decided after examination. Agree the follow-up arrangement before booking travel.

Questions and Appointments

Write to us on WhatsApp to discuss whether this approach is relevant to your case, directly with Dr. Aykut Gürel. International patient appointments are planned at Dentopol Ümraniye on Mondays, Wednesdays and Saturdays, 09:00–18:00 Istanbul time.

Dr. Gürel speaks English. Written messages in other languages can be supported by translation; please confirm the availability of a spoken-language interpreter before your appointment. Treatment, follow-up and any transfer or accommodation arrangements are confirmed individually before you book travel.

References

• ITI — Evaluation of surgical techniques in survival rate and complications of zygomatic implants

• FDA — Dental implants: what you should know